BRPI0815181A2 - Compostos - Google Patents
CompostosInfo
- Publication number
- BRPI0815181A2 BRPI0815181A2 BRPI0815181A BRPI0815181A2 BR PI0815181 A2 BRPI0815181 A2 BR PI0815181A2 BR PI0815181 A BRPI0815181 A BR PI0815181A BR PI0815181 A2 BRPI0815181 A2 BR PI0815181A2
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2007/058408 WO2008022945A1 (de) | 2006-08-19 | 2007-08-14 | Arylsulfonamide mit analgetischer wirkung |
PCT/EP2008/052157 WO2009021758A1 (de) | 2007-08-14 | 2008-02-21 | Arylsulfonamide mit analgetischer wirkung |
EP08102043A EP2025673A1 (de) | 2007-08-14 | 2008-02-26 | Arylsulfonamide mit analgetischer Wirkung |
PCT/EP2008/060562 WO2009021944A1 (de) | 2007-08-14 | 2008-08-12 | Neue verbindungen |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0815181A2 true BRPI0815181A2 (pt) | 2015-03-31 |
Family
ID=40589564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0815181 BRPI0815181A2 (pt) | 2007-08-14 | 2008-08-12 | Compostos |
Country Status (21)
Country | Link |
---|---|
US (1) | US8394805B2 (pt) |
EP (1) | EP2188269B1 (pt) |
JP (1) | JP5250627B2 (pt) |
KR (1) | KR20100055469A (pt) |
CN (1) | CN101821245B (pt) |
AR (1) | AR068341A1 (pt) |
AU (2) | AU2008288431A1 (pt) |
BR (1) | BRPI0815181A2 (pt) |
CA (1) | CA2696261A1 (pt) |
CO (1) | CO6331335A2 (pt) |
EA (1) | EA201000296A1 (pt) |
EC (1) | ECSP109978A (pt) |
MA (1) | MA31613B1 (pt) |
MX (1) | MX2010001664A (pt) |
NZ (1) | NZ583815A (pt) |
PE (1) | PE20090593A1 (pt) |
TN (1) | TN2010000072A1 (pt) |
TW (1) | TW200911744A (pt) |
UY (1) | UY31287A1 (pt) |
WO (1) | WO2009021944A1 (pt) |
ZA (1) | ZA201008350B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006039003A1 (de) | 2006-08-19 | 2008-02-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Verbindungen |
EP2188269B1 (de) | 2007-08-14 | 2014-05-07 | Boehringer Ingelheim International GmbH | Arylsulfonamide mit analgetischer wirkung |
EP2025675A1 (de) | 2007-08-14 | 2009-02-18 | Boehringer Ingelheim International GmbH | Arylsulfonamide mit analgetischer Wirkung |
CA2712582A1 (en) * | 2008-02-06 | 2009-08-13 | Norbert Hauel | Aryl sulfonamides as effective analgesics |
US20110301350A1 (en) * | 2008-08-12 | 2011-12-08 | Boehringer Ingelheim International Gmbh | Process for preparing cycloalkyl-substituted piperazine compounds |
US8207335B2 (en) * | 2009-02-13 | 2012-06-26 | Boehringer Ingelheim International Gmbh | Process for making certain compounds having B1 antagonistic activity |
JP2013535480A (ja) * | 2010-08-05 | 2013-09-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 2−[2−[[(4−メトキシ−2,6−ジメチルフェニル)スルホニル]−(メチル)アミノ]エトキシ]−n−メチル−n−[3−(4−メチルピペラジン−1−イル)シクロヘキシル]アセトアミドの酸付加塩及びそのブラジキニンb1受容体アンタゴニストとしての使用 |
WO2012022796A2 (de) | 2010-08-20 | 2012-02-23 | Boehringer Ingelheim International Gmbh | Neue kombinationen |
EP2611810A1 (en) | 2010-09-03 | 2013-07-10 | Grünenthal GmbH | Substituted tetrahydropyrrolopyrazine derivatives |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3584341D1 (de) | 1984-08-24 | 1991-11-14 | Upjohn Co | Rekombinante dna-verbindungen und expression von polypeptiden wie tpa. |
IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
NZ540351A (en) | 1999-11-26 | 2006-05-26 | Shionogi & Co | NPY Y5 antagonists |
FR2819254B1 (fr) | 2001-01-08 | 2003-04-18 | Fournier Lab Sa | Nouveaux composes de la n-(phenylsulfonyl) glycine, leur procede de preparation et leur utilisation pour obtenir des compostions pharmaceutiques |
FR2840897B1 (fr) * | 2002-06-14 | 2004-09-10 | Fournier Lab Sa | Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique |
WO2004056319A2 (en) | 2002-12-19 | 2004-07-08 | Elan Pharmaceuticals Inc. | Substituted n-phenyl sulfonamide bradykinin antagonists |
CN1756551A (zh) * | 2003-01-31 | 2006-04-05 | 普雷迪克医药品控股公司 | 新型芳基哌嗪基化合物 |
US7538111B2 (en) | 2003-03-25 | 2009-05-26 | Laboratoires Fournier S.A. | Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain |
US7521457B2 (en) | 2004-08-20 | 2009-04-21 | Boehringer Ingelheim International Gmbh | Pyrimidines as PLK inhibitors |
WO2006036664A1 (en) * | 2004-09-23 | 2006-04-06 | Amgen Inc. | Substituted sulfonamidopropionamides and methods of use |
US20080090863A1 (en) | 2004-09-30 | 2008-04-17 | Taisho Pharmaceutical Co., Ltd. | Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor |
DE102005013967A1 (de) | 2004-11-05 | 2006-10-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Bradykinin-B1-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
WO2006071775A2 (en) | 2004-12-29 | 2006-07-06 | Elan Pharmaceuticals, Inc. | Novel compounds useful for bradykinin b1 receptor antagonism |
EP2155689B1 (en) | 2007-05-31 | 2015-07-08 | Boehringer Ingelheim International GmbH | Ccr2 receptor antagonists and uses thereof |
DE102007034620A1 (de) | 2007-07-25 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue B1-Antagonisten |
US20110077231A1 (en) | 2007-08-14 | 2011-03-31 | Boehringer Ingelheim International Gmbh | Compounds |
EP2188269B1 (de) | 2007-08-14 | 2014-05-07 | Boehringer Ingelheim International GmbH | Arylsulfonamide mit analgetischer wirkung |
DE102007046887A1 (de) | 2007-09-28 | 2009-04-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung von (1R,5S)-Anhydroecgoninestersalzen |
-
2008
- 2008-08-12 EP EP08803005.1A patent/EP2188269B1/de active Active
- 2008-08-12 CN CN2008801116296A patent/CN101821245B/zh not_active Expired - Fee Related
- 2008-08-12 BR BRPI0815181 patent/BRPI0815181A2/pt not_active Application Discontinuation
- 2008-08-12 CA CA2696261A patent/CA2696261A1/en not_active Abandoned
- 2008-08-12 EA EA201000296A patent/EA201000296A1/ru unknown
- 2008-08-12 PE PE2008001366A patent/PE20090593A1/es not_active Application Discontinuation
- 2008-08-12 AU AU2008288431A patent/AU2008288431A1/en not_active Abandoned
- 2008-08-12 NZ NZ583815A patent/NZ583815A/en not_active IP Right Cessation
- 2008-08-12 KR KR1020107005536A patent/KR20100055469A/ko not_active Application Discontinuation
- 2008-08-12 US US12/672,460 patent/US8394805B2/en active Active
- 2008-08-12 JP JP2010520555A patent/JP5250627B2/ja active Active
- 2008-08-12 WO PCT/EP2008/060562 patent/WO2009021944A1/de active Application Filing
- 2008-08-12 MX MX2010001664A patent/MX2010001664A/es active IP Right Grant
- 2008-08-13 UY UY31287A patent/UY31287A1/es not_active Application Discontinuation
- 2008-08-13 AR ARP080103538A patent/AR068341A1/es unknown
- 2008-08-13 TW TW097130828A patent/TW200911744A/zh unknown
-
2009
- 2009-02-13 AU AU2009281472A patent/AU2009281472A1/en not_active Abandoned
-
2010
- 2010-02-12 CO CO10016009A patent/CO6331335A2/es active IP Right Grant
- 2010-02-12 TN TNP2010000072A patent/TN2010000072A1/fr unknown
- 2010-02-15 MA MA32623A patent/MA31613B1/fr unknown
- 2010-02-19 EC EC2010009978A patent/ECSP109978A/es unknown
- 2010-11-22 ZA ZA2010/08350A patent/ZA201008350B/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ583815A (en) | 2012-03-30 |
AU2008288431A1 (en) | 2009-02-19 |
PE20090593A1 (es) | 2009-06-03 |
ECSP109978A (es) | 2010-03-31 |
US8394805B2 (en) | 2013-03-12 |
MA31613B1 (fr) | 2010-08-02 |
KR20100055469A (ko) | 2010-05-26 |
JP5250627B2 (ja) | 2013-07-31 |
EP2188269A1 (de) | 2010-05-26 |
EP2188269B1 (de) | 2014-05-07 |
TW200911744A (en) | 2009-03-16 |
CO6331335A2 (es) | 2011-10-20 |
WO2009021944A1 (de) | 2009-02-19 |
TN2010000072A1 (en) | 2011-09-26 |
MX2010001664A (es) | 2010-03-10 |
CN101821245A (zh) | 2010-09-01 |
ZA201008350B (en) | 2011-08-31 |
CN101821245B (zh) | 2012-10-10 |
AR068341A1 (es) | 2009-11-11 |
CA2696261A1 (en) | 2009-02-19 |
UY31287A1 (es) | 2009-04-30 |
AU2009281472A1 (en) | 2010-02-18 |
JP2010535839A (ja) | 2010-11-25 |
EA201000296A1 (ru) | 2010-08-30 |
US20110098282A1 (en) | 2011-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0813500A2 (pt) | Compostos antivirais | |
BRPI0821086A2 (pt) | Compostos inseticidas | |
ATE502948T1 (de) | Substituierte bicyclolactamverbindungen | |
BRPI0815042A2 (pt) | Compostos de pirazol | |
DK2288375T3 (da) | Pegylerede insulin-lispro-forbindelser | |
BRPI0920707A2 (pt) | compostos | |
ATE542825T1 (de) | Substituierte piperidino-dihydrothienopyrimidine | |
DK2242759T3 (da) | Forbindelser | |
BRPI0821573A2 (pt) | benzofuropirimidonas | |
BRPI0811264A2 (pt) | Compostos | |
ATE514696T1 (de) | Diphenyl-dihydro-imidazopyridinone | |
DK2323972T3 (da) | C7-fluor-substituerede tetracylinforbindelser | |
BRPI0814424A2 (pt) | Compostos heterociclila | |
BRPI0814519A2 (pt) | Organopolissiloxano | |
BRPI0811451A2 (pt) | Exopolissacarídeo | |
DK2297162T3 (da) | Forbindelser | |
BRPI0812840A2 (pt) | 2-imidazolinas | |
BRPI0815547A2 (pt) | Depsipeptídeos cícliocos | |
AT505058A3 (de) | Türschliesssystem | |
BRPI0812994A2 (pt) | Microbiocidas | |
BRPI0809996A2 (pt) | Compostos | |
BRPI0916432A2 (pt) | compostos | |
BRPI0815181A2 (pt) | Compostos | |
DK2206698T3 (da) | Ethynylindolforbindelser | |
BRPI0922152A2 (pt) | Compostos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |